Literature DB >> 14760750

Modulation of tryptase secretion from human colon mast cells by histamine.

Shao-Heng He1, Hua Xie.   

Abstract

AIM: To investigate the ability of histamine to modulate tryptase release from human colon mast cells and the potential mechanisms.
METHODS: Enzymatically dispersed cells from human colons were challenged with histamine, anti-IgE or calcium ionophore A23187 (CI), and the cell supernatants after challenge were collected. Tryptase release was determined with a sandwich ELISA procedure.
RESULTS: Histamine at concentrations from 1 ng/mL was able to induce a "bell" shape dose related release of tryptase from colon mast cells. The maximum release of tryptase was approximately 3.5 fold more than spontaneous release. As little as 10 ng/mL histamine showed a similar potency to 10 microg/mL anti-IgE in induction of tryptase release. Histamine induced release of tryptase initiated at 10 s when histamine (100 ng/mL) was added to cells, gradually increased thereafter, and completed at 5 min. Both pertussis toxin or metabolic inhibitors were able to inhibit histamine induced tryptase release. When histamine and anti-IgE were added to colon mast cells at the same time, the quantity of tryptase released was similar to that induced by anti-IgE alone. The similar results were observed with CI. However, when various concentrations of histamine were incubated with cells for 20 min before adding anti-IgE or CI, the quantity of tryptase released was similar to that was induced by histamine alone.
CONCLUSION: Histamine is a potent activator of human colon mast cells, which represents a novel and pivotal self-amplification mechanism of mast cell degranulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760750      PMCID: PMC4724929          DOI: 10.3748/wjg.v10.i3.323

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms.

Authors:  Shao-Heng He; Hua Xie; Yong-Song He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions.

Authors:  D Proud; G S Bailey; R M Naclerio; C J Reynolds; A A Cruz; P A Eggleston; L M Lichtenstein; A G Togias
Journal:  J Allergy Clin Immunol       Date:  1992-06       Impact factor: 10.793

3.  Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase.

Authors:  D Laroche; M C Vergnaud; B Sillard; H Soufarapis; H Bricard
Journal:  Anesthesiology       Date:  1991-12       Impact factor: 7.892

4.  Responsiveness of human skin mast cells to repeated activation: an in vitro study.

Authors:  E Rubinchik; M Shalit; F Levi-Schaffer
Journal:  Allergy       Date:  1998-01       Impact factor: 13.146

5.  Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.

Authors:  C C Fox; L M Lichtenstein; J K Roche
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

6.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

Authors:  L B Schwartz; D D Metcalfe; J S Miller; H Earl; T Sullivan
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

7.  A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.

Authors:  S He; M D Gaça; A F Walls
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

8.  Mast cells and inflammatory mediators in chronic ulcerative colitis.

Authors:  Irina I Stoyanova; Maya V Gulubova
Journal:  Acta Histochem       Date:  2002       Impact factor: 2.479

9.  Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor.

Authors:  Adrian M Piliponsky; Gerald J Gleich; Arnon Nagler; Ilan Bar; Francesca Levi-Schaffer
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

10.  Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.

Authors:  Yoshiyuki Nishida; Kunihiko Murase; Hajime Isomoto; Hisashi Furusu; Yohei Mizuta; Robert H Riddell; Shigeru Kohno
Journal:  Hepatogastroenterology       Date:  2002 May-Jun
View more
  6 in total

Review 1.  Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases.

Authors:  Kim E Barrett
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

2.  Cross-sensitization of histamine-independent itch in mouse primary sensory neurons.

Authors:  T Akiyama; M Tominaga; A Davoodi; M Nagamine; K Blansit; A Horwitz; M I Carstens; E Carstens
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

3.  Cloning and expression of human colon mast cell carboxypeptidase.

Authors:  Zhang-Quan Chen; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 4.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

5.  Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2.

Authors:  Shao-heng He; Hua Xie; Yi-ling Fu
Journal:  Acta Pharmacol Sin       Date:  2005-05       Impact factor: 6.150

6.  A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.

Authors:  David Díaz-Jiménez; Lucía Núñez; Marjorie De la Fuente; Karen Dubois-Camacho; Hugo Sepúlveda; Martín Montecino; Alejandro Torres-Riquelme; Paulina García-González; Jonás Chnaiderman; Anna Vossenkamper; Thomas T MacDonald; Daniela Simian; María-Julieta González; John A Cidlowski; Rodrigo Quera; Marcela A Hermoso
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.